Advanced search×

Time of celebration of decades of excellence.

Nuggehally R Srinivas

Biomed Chromatogr 24(1):1 (2009) PMID 20017123

DOI: 10.1002/bmc.1366
Version: za2963e q8zaa q8zb4 q8zc3 q8zd3 q8ze1 q8zfd q8zg8

Similar articles you may find interesting…

  1. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retro...
    Mani M Kandasamy, Krishnanand K Tripathy, ... Saral S Thangam

    Arzneimittelforschung 60(1):12-21 (2010) PMID 20184222

    Retrospective evaluation of fluoxetine and norfluoxetine pharmacokinetic data demonstrated existence of both PM and EM phenotypes in the Indian population. Based on the overall data (n=144 subjects) there appeared to be 10.4% of PM phenotypes for fluoxetine and/or possibly for other polymorphic CYP2...
  2. Comparison and suitability of gel matrix for entrapping higher content of enzymes for commercial applications.
    R Mahajan, V K Gupta, and J Sharma

    Indian J Pharm Sci 72(2):223-8 (2010) PMID 20838527

    We concluded that an enzyme or mixture of two or three enzymes can be immobilized in the same large sized calcium alginate beads. This will save the additional cost of bioreactor, manpower, maintenance conditions required for the conversion of one drug into another using enzyme/s entrapped in large...
    View PDF
  3. Commentary on Dartois et al.--model building in population PK-PD analyses. A 2002-2004 literature survey.
    Goonaseelan G Pillai and Jean-Louis JL Steimer

    Br J Clin Pharmacol 64(5):578-9 (2007) PMID 17764478 PMCID 2203264